Literature DB >> 10516332

Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat.

T L Wallace1, G A Gudelsky, C V Vorhees.   

Abstract

The neurochemical evidence of methamphetamine (MA)-induced toxicity to dopaminergic nerve terminals is well documented; however, the functional consequences are not clearly defined. The present study was designed to investigate whether MA-induced dopamine depletions affect locomotor activity, stereotypic behavior, and/or extracellular dopamine concentrations in the neostriatum. Male rats were treated with a neurotoxic regimen of MA (10 mg/kg, i.p., every 2 hr for four injections) or vehicle and tested for functional effects 1 week later. Animals that had received the neurotoxic regimen of MA showed a reduction in both caudate nucleus and nucleus accumbens dopamine contents of 56 and 30%, respectively. Furthermore, MA-treated rats exhibited a significant attenuation in spontaneous activity, as well as a significant diminution in MA (low dose)-stimulated locomotor activity as compared to vehicle-treated rats. However, there were no differences in the MA (low dose)-induced increases in extracellular dopamine concentrations in the caudate nucleus or the nucleus accumbens core of either group. Interestingly, the acute administration of higher doses of MA elicited a significantly augmented stereotypic response and a significantly attenuated increase in the extracellular concentration of dopamine in the caudate nucleus of rats treated with a neurotoxic regimen of MA as compared to vehicle-treated animals. These data indicate that MA-induced neurotoxicity results in abnormal dopamine-mediated behaviors, as well as a brain region-specific impairment in stimulated dopamine release.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516332      PMCID: PMC6782759     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion.

Authors:  T E Robinson; D M Camp
Journal:  Pharmacol Biochem Behav       Date:  1987-04       Impact factor: 3.533

2.  Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.

Authors:  W C Graham; A R Crossman; G N Woodruff
Journal:  Brain Res       Date:  1990-04-23       Impact factor: 3.252

3.  Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates.

Authors:  D S Segal; R Kuczenski
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

4.  Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.

Authors:  C J Schmidt; J W Gibb
Journal:  Eur J Pharmacol       Date:  1985-02-12       Impact factor: 4.432

5.  Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics.

Authors:  R Kuczenski; D S Segal; M L Aizenstein
Journal:  J Neurosci       Date:  1991-09       Impact factor: 6.167

6.  Methamphetamine-induced changes in activity and water intake during light and dark cycles in rats.

Authors:  T Kita; M Takahashi; G C Wagner; K Kubo; T Nakashima
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1998-10       Impact factor: 5.067

7.  Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity.

Authors:  E M Joyce; L Stinus; S D Iversen
Journal:  Neuropharmacology       Date:  1983-09       Impact factor: 5.250

8.  Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity.

Authors:  R K Mishra; E L Gardner; R Katzman; M H Makman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

9.  Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

Authors:  J F Cubells; S Rayport; G Rajendran; D Sulzer
Journal:  J Neurosci       Date:  1994-04       Impact factor: 6.167

10.  Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.

Authors:  J P O'Callaghan; D B Miller
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

View more
  45 in total

1.  Biphasic effects of selegiline on striatal dopamine: lack of effect on methamphetamine-induced dopamine depletion.

Authors:  K Grasing; R Azevedo; S Karuppan; S Ghosh
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

Review 2.  Functional aspects of estrogen neuroprotection.

Authors:  Veronica Bisagno; Rachel Bowman; Victoria Luine
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

3.  Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects.

Authors:  Young-Hoon Sung; Deborah A Yurgelun-Todd; Douglas G Kondo; Xian-Feng Shi; Kelly J Lundberg; Tracy L Hellem; Rebekah S Huber; Erin C McGlade; Eun-Kee Jeong; Perry F Renshaw
Journal:  Am J Drug Alcohol Abuse       Date:  2015-04-14       Impact factor: 3.829

4.  Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity.

Authors:  Lir-Wan Fan; Lu-Tai Tien; Baoying Zheng; Yi Pang; Rick C S Lin; Kimberly L Simpson; Tangeng Ma; Philip G Rhodes; Zhengwei Cai
Journal:  Brain Behav Immun       Date:  2010-09-27       Impact factor: 7.217

Review 5.  Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.

Authors:  Jue He; Jiming Kong; Qing-Rong Tan; Xin-Min Li
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

Review 6.  Fetal effects of psychoactive drugs.

Authors:  Amy L Salisbury; Kathryn L Ponder; James F Padbury; Barry M Lester
Journal:  Clin Perinatol       Date:  2009-09       Impact factor: 3.430

7.  Progesterone in transient ischemic stroke: a dose-response study.

Authors:  Seema Yousuf; Fahim Atif; Iqbal Sayeed; Huiling Tang; Donald G Stein
Journal:  Psychopharmacology (Berl)       Date:  2014-04-22       Impact factor: 4.530

8.  Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment.

Authors:  Tori L Schaefer; Matthew R Skelton; Nicole R Herring; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

9.  Effect of sulpiride on the amphetamine-induced changes in extracellular dopamine, DOPAC, and hydroxyl radical generation in the rat striatum.

Authors:  Elmira Anderzhanova; Kirill S Rayevsky; Pirjo Saransaari; Simo S Oja
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

10.  Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens.

Authors:  Toni L Richards; Nancy R Zahniser
Journal:  J Neurochem       Date:  2009-01-22       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.